Bayer shares sag after U.S. jury verdict in Roundup cancer trial

Bayer AG shares sank to their lowest in almost seven years on Thursday after a U.S. jury awarded $80 million to a man who claimed use of the group's weed killer Roundup caused his cancer, with thousands of similar lawsuits looming.

from Reuters: Top News https://ift.tt/2CKv9BE
via IFTTT